Department of Defense explores AI-enabled infection control

The technology examines vital signs and other biomarkers to predict the likelihood of infection


The technology, developed in part by the U.S. Department of Defense (DoD), examines vital signs and other biomarkers to predict the likelihood of infection up to 48 hours ahead of clinical suspicion, according to an article on the Healthcare IT News website.

The technology is intended for U.S. service members but expected to be used widely by civilians. 

The healthcare technology company, Royal Philips, and the DoD collaborated on the 18-month project.

The technology is expected to be broadly applicable to civilian healthcare settings. It will eventually be used in scenarios where vital signs and biomarkers fluctuate, like during physical exertion and heat stress.

Read the article.



October 29, 2019


Topic Area: Infection Control


Recent Posts

What Does Light Daily Cleaning Miss in Patient Rooms?

Most environmental services workers still clean as if they are wiping dust off a countertop, not disrupting a living, structured community.


Smart Lighting Overhaul Boosts Efficiency, Diagnostics and Wellness at Bryan Health

Case study: LED upgrade and advanced controls across Bryan Health campuses cut lighting energy use by 57 percent while enhancing patient care and staff productivity.


AdventHealth Opens New Freestanding ER in Florida

The approximately 13,700-square-foot emergency room features 12 patient rooms, respiratory therapy services, diagnostic imaging including CT scans, X-ray and ultrasound.


Dirty Floors: How Pathogens Can Accumulate and Spread Underfoot

Studies show that healthcare floors are covered in bacteria and can quickly spread throughout patient rooms. 


WellSpan Health Opens Its Newberry Hospital in Pennsylvania

This marks the opening of its 10th hospital in the region spanning Central Pennsylvania and Northern Maryland.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.